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ABSTRACT
In the current setting of global containment, peritoneal dialysis (PD) and home haemodialysis are the best modalities of
renal replacement therapy (RRT) to reduce the rate of transmission of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection. Considering the shorter and easier training programme of PD compared to home haemodialysis, PD
appears a practical solution for patients with end-stage renal disease to reduce the risk of hospital-acquired infection. PD
offers the advantage of minimizing the risk of viral transmission through interpersonal contact that commonly occurs
during the haemodialysis session and while travelling from home to the haemodialysis facility using public transport
services. To overcome barriers to health care access due to the containment measures for this emerging disease,
telemedicine is a useful and reliable tool for delivering health care without exposing patients to the risk of contact.
However, novel issues including handling of potentially infected dialysate, caregivers’ infectious risk and adequacy of PD in
critically ill patients with acute respiratory distress syndrome remain to be clarified. In conclusion, PD should be preferred
to the other modalities of RRT during the coronavirus disease 2019 (COVID-19) outbreak because it can be a solution to cope
with the increased number of infected patients worldwide.
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Coronavirus disease 2019 (COVID-19) is an emerging and con-
cerning infection, spreading globally from December 2019. The
disease is prevalently asymptomatic or paucisymptomatic, but
carries a 10–30% of mortality among hospitalized patients [1–
3]. The population with a worse outcome includes elderly sub-
jects affected by diabetes and hypertension [1, 2]. There is no
doubt that many patients on renal replacement therapy (RRT),
including those on peritoneal dialysis (PD), are at high risk for
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection. This vulnerable subset of the population, aged
>60 years, has a high amount of comorbidities including meta-
bolic and cardiovascular diseases [4].
In these circumstances, the main advantage of patients be-
ing on PD is that they can carry out the dialysis treatment in
their own homes. Performing home dialysis treatment, a PD pa-
tient can minimize interpersonal contact by avoiding the need
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to reach the haemodialysis facility three times a week. In addi-
tion, the patient nullifies exposure to the virus while travelling
from home to the centre on public transport services and wait-
ing for the start of the dialysis treatment. In addition, PD
patients have the advantage of reducing close contact with
health-care workers, who can be potentially affected by SARS-
CoV-2 infection [5]. PD appears, therefore, as the best RRT for
patients with end-stage kidney disease during the COVID-19
outbreak, as contact plays a crucial role in the spread of this in-
fectious disease.
With the rapid spread of the virus in Northern Italy, we have
faced a new condition never experienced before. The increase
in the number of notified cases of COVID-19 has been rapid,
with very little time to manage this evolving situation. The
national public health response has been focused on the treat-
ment of severely ill SARS-COV-2-infected patients, with a re-
distribution of the medical services according to a priority set-
ting of health interventions. As a result, radical changes have
been made to the care of PD patients as a consequence of new
and emerging COVID-19-related issues (Table 1).
According to the recommendation of the World Health
Organization [6] and International Society for Peritoneal
Dialysis [7], delivery of health care services for PD patients has
undergone profound changes in response to the COVID-19 out-
break. Telemedicine has been implemented first in clinical
practice. This umbrella term encompasses all health-care serv-
ices delivery at a distance using electronic means including
phone, webcam or other electronic devices. Knowing the
patient’s health conditions, despite this emerging situation, is
fundamental to maintain a high standard of care and a stable
patient–clinician relationship. Data about body weight, diuresis,
peritoneal ultrafiltration, arterial blood pressure and heart rate
are indispensable to recognize variation from the baseline. In
absence of signs or symptoms of inadequate depuration, periodic
PD clinic visits, normally scheduled every 4 weeks, can be length-
ened to 8–10 weeks, according to the clinical characteristics of the
patients. Furthermore, we have noted that maintaining a regular
relationship with the patient can help to relieve anxiety and vul-
nerability caused by this stressful situation.
A preventive telephonic triage is required to screen patients
and caregivers for symptoms of acute respiratory illness (e.g. fe-
ver, cough, shortness of breath) before coming to our facility.
Health-care providers should maintain a high index of suspi-
cion for all patients, and a triage system must be set up to inter-
cept suspected cases. Symptomatic patients are addressed,
according to the local policy, to facilities or a specialized team
able to screen for SARS-CoV-2 infection. An alternative strategy
is to direct the patient, wearing a surgical mask, into a separate
area (an isolation room if available). At least 1 m distance must
be kept from other patients [6]. According to our local policy, a
febrile patient, even if there is suspicion for bacterial peritonitis,
is treated as a suspected case and invited to present to the
emergency room, where lab examinations, chest X-ray and
swab for SARS-CoV-2 are rapidly performed.
Based on our limited experience (two confirmed cases), a
high-level alert is required to ensure early diagnosis and appro-
priate management of COVID-19. Briefly, the first patient (72
years) with a medical history of ischaemic heart disease
reported dyspnoea and fever at the time of admission. The ra-
diologic signs of acute pulmonary oedema were misleading and
led towards a primary diagnosis of heart failure due to fluid
overload. Atypical pneumonia was mild and the subject had a
good prognosis. The second patient (64 years), who had been
self-isolated at home for SARS-CoV-2 infection, was admitted
for hypoxaemia due to a rapid worsening of pulmonary func-
tion. Severe lung involvement and multiple comorbidities led to
Table 1. Emerging COVID-19-related issues in PD
COVID-related issue Strategy
Restricted access to PD facility Routine use of telemedicine
Replace in-centre visit with on-demand or scheduled appointment
PD urgency Telephone triage to screening for COVID-19-related symptoms
Pre-facility triage
Do not exclude COVID-19, consider nasopharyngeal swab in patients
with suspicious SARS-CoV-2 infection
PD patient with COVID-19 at home Close monitoring of vital signs (breathing rate, oxygen saturation, fe-
ver, dyspnoea)
Low threshold for hospital admission
PD patient with COVID-19 in hospital or health care facility Consider low-volume APD for mild ARDS (maintain a low IAP with
small fill volume)
Consider a switch to extracorporeal dialysis for moderate to severe
ARDS or worsening of oxygenation and/or mechanical ventilator
parameters following instillation of peritoneal dialysate
PD patient in prone positioning requires abdomen suspension to allow
dialysis exchanges and peritoneal UF
Peritoneal dialysate effluent and disposable material Consider peritoneal fluid and disposable material potentially infec-
tious (see local regulation for safe disposal)
Supply of PD material Some companies can limit the delivery of PD supplies at one delivery
location to once in every 30 days
People in close contact with COVID-19 patient
(e.g. caregiver, delivery driver of PD companies)
According to local privacy regulations, alert caregiver or others of the
high transmissibility of the infection
Use of PPE
SARS-CoV-2 re-infection Monitor nasopharyngeal swabs and serologic tests
ARDS, acute respiratory distress syndrome; IAP, intra-abdominal pressure;PD peritoneal dialysis; PPE, personal protective equipment;UF, ultrafiltration.
266 | G. Alfano et al.
an unfavourable clinical course; he died of sepsis 7 days after
admission.
The latter case underlines that frail patients, even with mild
symptoms, need close monitoring of their respiratory function
to prevent the risk of a severe tardive presentation. Patients in
self-isolation at home must regularly check body temperature
and oxygen saturation by pulse oximetry. To better evaluate the
pulmonary function, oxygen saturation should be measured
also after a moderate effort such as a 6-min self-paced walking.
Decrease of oxygen saturation under the cut-off of 93% in
patients not affected by lung disease needs specialist evaluation
and chest X-ray. Another parameter that is particularly useful is
the measurement of the breathing rate [8]; a value >25 breaths
per minute is used in clinical practice as a sign of respiratory
distress.
Admitted PD patients waiting for an oropharyngeal swab
test result or having a documented infection should be treated
with all precautions, which range from a negative pressure
room to personal protective equipment (PPE). A minimum num-
ber of health-care workers and medical devices should be ex-
posed to the case, and contact should be limited in duration to
reduce virus transmission. These precautions are also valid for
patients necessitating a caregiver at home.
The main issue that has been raised during the COVID-19
outbreak is the risk of contamination with the handling of
dialysate.SARS-CoV-2 has been recently identified in PD efflu-
ent, but it is unclear if the virus has the potential to replicate [9].
Viral RNA was also documented in peritoneal fluid during SARS
outbreak in 2003 [10]. These findings show that dialysate is a
potential source of the most severe strains of coronavirus and
therefore, should be managed very cautiously. Safe disposal of
PD effluent is subject to local regulation. For PD patients on au-
tomated peritoneal dialysis (APD), the discharge dialysate
should be drained, through an extension line, below the surface
of the water of the toilet bowl or tank to avoid the spread of
aerosols generated from the contaminated fluid. Self-sufficient
patients on continuous ambulatory peritoneal dialysis should
pour the discharge dialysate into the toilet bowl. Health-care
workers or caregivers should decontaminate the bag with so-
dium hypochlorite and throw the intact bag out in unsorted gar-
bage; otherwise, the drain bag should be poured into the toilet
bowl. PPE is necessary to prevent infection from aerosol
droplets.
Another issue of great interest is the impact of PD on pulmo-
nary function. Given that COVID-19 manifests with respiratory
symptoms and hypoxia, the choice to continue PD in patients
with respiratory distress should be considered very carefully.
PD has the potential to compromise respiratory function. Early
studies in PD patients demonstrated that 2 L of dialysis fluid in
the abdomen resulted in a reduction of most lung volumes,
impairing blood oxygenation due to ventilation–perfusion mis-
match [11]. It was established that PD treatment was associated
with a decrease of 8 mmHg of arterial PO2 in the supine position.
A long-term adjustment including the re-distribution of blood
away from the scarcely ventilated segments of the lungs seem
to nullify the decrement of O2 [12], albeit the reduction of the
functional residual capacity can persist. Prone ventilation is a
useful strategy utilized to ameliorate oxygenation and lung me-
chanics in patients with severely hypoxaemic acute respiratory
distress syndrome (ARDS) [13]. The survival benefit of prone po-
sitioning [14] appears to depend on the recruitment of dorsal
lung units, improvement of ventilation/perfusion matching and
prevention of ventilator-induced lung injury [15, 16]. A single
case documents the successful use of prone ventilation in a
hypoxaemic PD patient with neurogenic pulmonary oedema.
The risk of intra-abdominal hypertension due to the installation
of peritoneal dialysate was counteracted with the prescription
of an APD programme of 40 L for >24 h and the maintenance of
the intra-abdominal pressure <18 mmHg [17].
In light of this evidence, the prescription of a low-volume
APD programme can be a solution in patients with mild ARDS
(200<PaO2/FiO2300 mmHg) [18]. In intubated patients, PD
should be performed in prone position along with the suspen-
sion of the abdominal cavity. This strategy allows unloading the
abdomen to avoid an undesirable rise of intra-abdominal pres-
sure, especially in patients with a large abdomen that protrudes
beyond the ribcage [19]. Maintaining low intra-abdominal pres-
sure is mandatory to achieve desiderate ultrafiltration and fa-
vour lung mechanics.
A temporary switch to haemodialysis or continuous RRT is
advocated in severely ill PD patients with severely compro-
mised lung function and patients with a worsening of ventilator
parameters following the instillation of peritoneal dialysate (i.e.
tidal volume, FiO2, positive end expiratory pressure, etc.).
According to the current global containment strategies, PD is
the best dialysis modality to prevent cross-infection in dialysis
patients and diffusion of the virus in health-care facilities. The
principal limiting factor that counterbalances the benefit of
home dialysis is the currently limited assistance that can derive
from the reduction of essential health services during COVID-19
outbreak. For this reason, additional efforts, such as the imple-
mentation of telemedicine services, should be made to main-
tain a high standard of care and to endorse the high benefit of
home dialysis over in-centre haemodialysis.
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